Australia's largest stock trading and investment forum Australia's #1 stock forum

ADN

11.1%

0.8¢ andromeda metals limited

Halloysite, Halloysite and Halloysite!!, page-666

First 666 Last

Share
Profile

Follow
Mugse

887 Posts.

89

14/11/21

14:40

Post #: 57563168
Share

Originally posted by Waynecarey: ↑

Halloysite used to deliver drug for treatment of covid.

https://www.sciencedirect.com/science/article/pii/S0169131721003574

AbstractDexamethasone (Dex) is used in drug regimen for treatment of Coronavirus disease (COVID-19). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) fusion and entry into the cell occurs at pH 5.5. In our present study, we have identified a green, cheap clay based halloysite (Hal) nanoformulation with release capability of Dex at such interactive pH condition. 30%ZnFe2O4/Hal and 30%NiFe2O4/Hal were prepared by one-pot synthesis technique. Dex (5% wt/wt) was functionalized over both nanocomposites. Finally, polyethylene glycol (PEG) was coated over ZnFe2O4/Hal/Dex and NiFe2O4/Hal/Dex nanocomposite using lyophilization technique (0.08 μl/mg of nanocarrier). The release ability of Dex was studied under pulmonary infection and normal pH conditions (pH = 5.6 and 7.4). The characterization study using X-ray diffraction (XRD) and UV–visible diffuse reflectance (DRS) spectra confirmed the presence of spinel ferrites over Hal. Nitrogen adsorption isotherm showed the surface area of ZnFe2O4/Hal (75 m2/g), pore volume (0.27 cm3/g) with average pore size (14.5 nm). Scanning electron microscope/Energy dispersive spectroscopy (SEM-EDS) and Transmission electron microscopy analysis revealed a textural change in halloysite tubular type indicating drug adsorption and PEG adhesion. DRS spectra indicated an intergrowth of zinc ferrite nanoparticles on the halloysite nanotubes. Interestingly, ZnFe2O4/Hal/Dex/PEG exhibited a high Dex release ability (17.5%, 168 h) at pH = 5.6 relevant to SARS-CoV-2 fusion entry into the cell pH condition of 5.5. Comparatively, the nanocomposite showed a less Dex release (<5%) release for 168 h at neutral pH = 7.4. The drug release kinetics were studied and the obtained data were fitted for the release constant and release exponent, using the Korsmeyer-Peppas model. To test the compatibility of our nanocomposites, we performed the cell viability assay (MTT) using HEK293 cells. Our results showed that at 0.3 mg/ml, Dex-loaded nanocomposite had a statistically significant improvement in cell viability compared to Dex alone. These results suggest that our nanocomposite has prevented the toxic effect of Dex and has huge potential to act as pulmonary drug delivery system for targeted lung infection therapeutics.

Expand

For gods sake don't tell them it will push the DFS back.

ADN Price at posting: 17.0¢ Sentiment: Buy Disclosure: Held
19 Upvote

0 Great analysis

Reply

Top Stories

SKS

SKS secures $20M for extension works on Melbourne data centre

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

EBR

EBR Systems' heart pacing device on-target to reach the US market

BOE

Boss Energy ramps up as industrial-scale plant build continues; FY25 guidance of 850Klb intact

GDP grows 0.2% in June quarter, but annual growth the slowest since the 1990s

There are more pages in this discussion • 94 more messages in this thread...

First 666 Last

Add ADN (ASX) to my watchlist

(20min delay)
Last 0.8¢		Change -0.001(11.1%)		Mkt cap ! $27.14M

Open	High	Low	Value	Volume
0.8¢	0.9¢	0.8¢	$51.60K	6.217M

Buyers (Bids)

No.	Vol.	Price($)
48	20335090	0.8¢

Sellers (Offers)

Price($)	Vol.	No.
0.9¢	23148180	23

View Market Depth

No.	Vol.	Price($)
47	19735090	0.008
35	19469158	0.007
16	8436332	0.006
10	8025000	0.005
1	4500000	0.004

Price($)	Vol.	No.
0.009	23148180	23
0.010	24454328	15
0.011	16213479	8
0.012	23591434	8
0.013	2351111	6

Last trade - 16.10pm 04/09/2024 (20 minute delay)

ADN (ASX) Chart

Halloysite, Halloysite and Halloysite!!, page-666

SKS secures $20M for extension works on Melbourne data centre

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

EBR Systems' heart pacing device on-target to reach the US market

Boss Energy ramps up as industrial-scale plant build continues; FY25 guidance of 850Klb intact

GDP grows 0.2% in June quarter, but annual growth the slowest since the 1990s

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Halloysite, Halloysite and Halloysite!!, page-666

Top Stories

SKS secures $20M for extension works on Melbourne data centre

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

EBR Systems' heart pacing device on-target to reach the US market

Boss Energy ramps up as industrial-scale plant build continues; FY25 guidance of 850Klb intact

GDP grows 0.2% in June quarter, but annual growth the slowest since the 1990s

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News